• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化及其发病表型的家族风险和遗传性:一项病例对照研究。

The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.

机构信息

Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.

Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

出版信息

Mult Scler. 2023 Sep;29(10):1209-1215. doi: 10.1177/13524585231185258. Epub 2023 Jul 12.

DOI:10.1177/13524585231185258
PMID:37435869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10503245/
Abstract

BACKGROUND

The two main phenotypes of multiple sclerosis (MS), primary progressive (PPMS) and relapsing Onset (ROMS), show clinical and demographic differences suggesting possible differential risk mechanisms. Understanding the heritable features of these phenotypes could provide aetiological insight.

OBJECTIVES

To evaluate the magnitude of familial components in PPMS and ROMS and to estimate the heritability of disease phenotypes.

METHODS

We used data from 25,186 MS patients of Nordic ancestry from the Swedish MS Registry between 1987 and 2019 with known disease phenotype (1593 PPMS and 16,718 ROMS) and 251,881 matched population-based controls and 3,364,646 relatives of cases and controls. Heritability was calculated using threshold-liability models. For familial odds ratios (ORs), logistic regression with robust sandwich estimator was utilized.

RESULTS

The OR of MS diagnosis in those with a first-degree family member with ROMS was 7.00 and 8.06 in those with PPMS. The corresponding ORs for having a second-degree family member with ROMS was 2.16 and 2.18 in PPMS. The additive genetic effect in ROMS was 0.54 and 0.22 in PPMS.

CONCLUSION

Risk of MS increases by several folds in those with a relative with MS. The likelihood of developing either disease phenotype appears independent of genetic predisposition.

摘要

背景

多发性硬化症(MS)的两种主要表型,原发性进展型(PPMS)和复发性发病型(ROMS),表现出临床和人口统计学差异,表明可能存在不同的风险机制。了解这些表型的遗传特征可以提供病因学的见解。

目的

评估 PPMS 和 ROMS 中家族成分的大小,并估计疾病表型的遗传性。

方法

我们使用了来自瑞典多发性硬化症登记处 1987 年至 2019 年间的北欧血统的 25186 名 MS 患者的数据,这些患者已知疾病表型(1593 名 PPMS 和 16718 名 ROMS),并与 251881 名基于人群的对照和 3364646 名病例和对照的亲属进行了匹配。使用阈限 Liability 模型计算遗传度。对于家族优势比(OR),使用稳健的 sandwich 估计量进行逻辑回归。

结果

有 ROMS 一级亲属的 MS 诊断的 OR 为 7.00,有 PPMS 一级亲属的 OR 为 8.06。有 ROMS 二级亲属的 OR 分别为 2.16 和 2.18。在 ROMS 中,加性遗传效应为 0.54,在 PPMS 中为 0.22。

结论

有亲属患有 MS 的人患 MS 的风险增加了数倍。发展任何一种疾病表型的可能性似乎与遗传易感性无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7d/10503245/ba7bb61351d9/10.1177_13524585231185258-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7d/10503245/3f991e2f9e77/10.1177_13524585231185258-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7d/10503245/ba7bb61351d9/10.1177_13524585231185258-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7d/10503245/3f991e2f9e77/10.1177_13524585231185258-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7d/10503245/ba7bb61351d9/10.1177_13524585231185258-fig2.jpg

相似文献

1
The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.多发性硬化及其发病表型的家族风险和遗传性:一项病例对照研究。
Mult Scler. 2023 Sep;29(10):1209-1215. doi: 10.1177/13524585231185258. Epub 2023 Jul 12.
2
Multiple sclerosis by phenotype in Germany.德国基于表型的多发性硬化症。
Mult Scler Relat Disord. 2022 Jan;57:103326. doi: 10.1016/j.msard.2021.103326. Epub 2021 Oct 10.
3
Progression in familial and nonfamilial MS.家族性和非家族性多发性硬化症的进展
Mult Scler. 2008 Apr;14(3):300-6. doi: 10.1177/1352458507084269. Epub 2008 Jan 21.
4
Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.原发性进行性和复发缓解型多发性硬化症之间的遗传差异:免疫相关基因变异性的影响。
Mult Scler Relat Disord. 2019 Apr;29:130-136. doi: 10.1016/j.msard.2019.01.033. Epub 2019 Jan 24.
5
Genetics of primary progressive multiple sclerosis.原发性进行性多发性硬化症的遗传学
Handb Clin Neurol. 2014;122:211-30. doi: 10.1016/B978-0-444-52001-2.00042-X.
6
Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.复发型和进展型多发性硬化症患者的严重感染:一项德国索赔数据研究。
Mult Scler Relat Disord. 2022 Dec;68:104245. doi: 10.1016/j.msard.2022.104245. Epub 2022 Oct 17.
7
Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis.影响复发缓解型和进展型多发性硬化症发病风险的因素。
J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1096-1102. doi: 10.1136/jnnp-2020-325688. Epub 2021 May 13.
8
Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.原发性进行性多发性硬化症患者社会经济负担加重:一项基于丹麦全国人口的研究。
Mult Scler Relat Disord. 2020 Nov;46:102567. doi: 10.1016/j.msard.2020.102567. Epub 2020 Oct 10.
9
Disease onset in familial and sporadic primary progressive multiple sclerosis.家族性和散发性原发性进行性多发性硬化症的发病。
Mult Scler. 2010 Jun;16(6):694-700. doi: 10.1177/1352458510367661. Epub 2010 Apr 8.
10
Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.意大利原发性进行性多发性硬化症队列中 KIF1B 基因的缺失复制。
Eur J Neurol. 2010 May;17(5):740-5. doi: 10.1111/j.1468-1331.2009.02925.x. Epub 2010 Jan 7.

引用本文的文献

1
Multiple Sclerosis Polygenic Risk Is Not Enriched in Three Multicase Families in Comparison to Population-Based Cases.与基于人群的病例相比,多基因风险在三个多病例家庭中并未富集。
Hum Mutat. 2024 May 16;2024:9268911. doi: 10.1155/2024/9268911. eCollection 2024.
2
Linking Pathogenesis to Fall Risk in Multiple Sclerosis.将多发性硬化症的发病机制与跌倒风险相联系
Arch Intern Med Res. 2025;8(1):36-47. doi: 10.26502/aimr.0194. Epub 2025 Jan 30.
3
A comparative study of cognitive impairment in sporadic and familial cases of multiple sclerosis.

本文引用的文献

1
Magnetic Resonance Imaging in Primary Progressive Multiple Sclerosis Patients : Review.原发性进行性多发性硬化症患者的磁共振成像:综述。
Clin Neuroradiol. 2022 Sep;32(3):625-641. doi: 10.1007/s00062-022-01144-3. Epub 2022 Mar 8.
2
Genes and environment in multiple sclerosis: Impact of temporal changes in the sex ratio on recurrence risks.多发性硬化症中的基因与环境:性别比例的时变对复发风险的影响。
Mult Scler. 2022 Mar;28(3):359-368. doi: 10.1177/13524585211020221. Epub 2021 Jun 8.
3
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.
散发性和家族性多发性硬化症认知障碍的比较研究。
Sci Rep. 2025 Jan 4;15(1):788. doi: 10.1038/s41598-024-84779-1.
4
Increased Disability Progression in rs10191329 Carriers with Multiple Sclerosis Is Preceded by Neurofilament Light Chain Elevations.携带rs10191329的多发性硬化症患者残疾进展加剧之前,神经丝轻链会升高。
Ann Neurol. 2025 Mar;97(3):596-605. doi: 10.1002/ana.27144. Epub 2024 Nov 26.
5
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.首发多发性硬化症疾病调节治疗后 11 年内认知处理速度和身体残疾的轨迹。
J Neurol Neurosurg Psychiatry. 2024 Jan 11;95(2):134-141. doi: 10.1136/jnnp-2023-331784.
多发性硬化症基因组图谱提示外周免疫细胞和小胶质细胞与易感性有关。
Science. 2019 Sep 27;365(6460). doi: 10.1126/science.aav7188.
4
Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations.验证瑞典多发性硬化症登记处:进一步改进药物流行病学评估资源。
Epidemiology. 2019 Mar;30(2):230-233. doi: 10.1097/EDE.0000000000000948.
5
Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study.家族多发性硬化症发病早晚的风险:一项瑞典全国性研究。
J Neurol. 2019 Feb;266(2):481-486. doi: 10.1007/s00415-018-9163-6. Epub 2018 Dec 21.
6
The Swedish cause of death register.瑞典死亡原因登记册。
Eur J Epidemiol. 2017 Sep;32(9):765-773. doi: 10.1007/s10654-017-0316-1. Epub 2017 Oct 5.
7
Incorporation of the time aspect into the liability-threshold model for case-control-family data.将时间因素纳入病例对照家系数据的责任阈值模型。
Stat Med. 2017 May 10;36(10):1599-1618. doi: 10.1002/sim.7229. Epub 2017 Jan 23.
8
Similar familial risk in multiple sclerosis subgroups.多发性硬化亚组中存在相似的家族风险。
Mult Scler. 2017 Nov;23(13):1782-1785. doi: 10.1177/1352458516684214. Epub 2017 Jan 16.
9
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.多发性硬化症的遗传、生活方式和环境风险因素之间的相互作用。
Nat Rev Neurol. 2017 Jan;13(1):25-36. doi: 10.1038/nrneurol.2016.187. Epub 2016 Dec 9.
10
Twin studies in multiple sclerosis: A meta-estimation of heritability and environmentality.多发性硬化症的双胞胎研究:遗传度和环境影响的元估计
Mult Scler. 2015 Oct;21(11):1404-13. doi: 10.1177/1352458514564492. Epub 2015 Jan 12.